MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $27 | – | 100 | -50.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 200 | -71.4% | 0.00% | -100.0% |
| Q1 2021 | $2,000 | +100.0% | 700 | +40.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 500 | -58.3% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | 0.0% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -60.0% | 1,200 | -55.6% | 0.00% | -50.0% |
| Q1 2020 | $5,000 | -54.5% | 2,700 | -32.5% | 0.00% | -50.0% |
| Q4 2019 | $11,000 | -31.2% | 4,000 | +29.0% | 0.00% | -42.9% |
| Q3 2019 | $16,000 | -5.9% | 3,100 | +47.6% | 0.01% | -12.5% |
| Q2 2019 | $17,000 | +112.5% | 2,100 | +75.0% | 0.01% | +100.0% |
| Q1 2019 | $8,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
| NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
| Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
| AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
| MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
| Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
| Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
| NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |